IMODI Trademark

Trademark Overview


On Tuesday, April 11, 2017, a trademark application was filed for IMODI with the United States Patent and Trademark Office. The USPTO has given the IMODI trademark a serial number of 79211402. The federal status of this trademark filing is REGISTERED as of Tuesday, May 22, 2018. This trademark is owned by ONCODESIGN. The IMODI trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific and medical research in the field of cancerology; computer modeling services in the field of cancerology; development of experimental models of cancer; biomedical research; biological analyses and pharmacological analyses; consultancy pertaining to pharmacology; medical and scientific research in the field of cancer treatment and diagnosis, namely, molecular and pharmacological evaluation of the efficacy and toxicity of cancer treatments; scientific research, namely, identification of diagnostic, prognostic and predictive biomarkers in the field of cancerology; product development in relation to production of innovative biological models in vitro, ex vivo, in vivo and biological products for biomedical research in the field of cancerology; biomedical research services; analysis of translational biomedical data; design and development of computer software and databases for biomedical data processing and management
imodi

General Information


Serial Number79211402
Word MarkIMODI
Filing DateTuesday, April 11, 2017
Status700 - REGISTERED
Status DateTuesday, May 22, 2018
Registration Number5472060
Registration DateTuesday, May 22, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 6, 2018

Trademark Statements


Goods and ServicesScientific and medical research in the field of cancerology; computer modeling services in the field of cancerology; development of experimental models of cancer; biomedical research; biological analyses and pharmacological analyses; consultancy pertaining to pharmacology; medical and scientific research in the field of cancer treatment and diagnosis, namely, molecular and pharmacological evaluation of the efficacy and toxicity of cancer treatments; scientific research, namely, identification of diagnostic, prognostic and predictive biomarkers in the field of cancerology; product development in relation to production of innovative biological models in vitro, ex vivo, in vivo and biological products for biomedical research in the field of cancerology; biomedical research services; analysis of translational biomedical data; design and development of computer software and databases for biomedical data processing and management

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 7, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameONCODESIGN SERVICES
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressFR

Party NameONCODESIGN
Party Type30 - Original Registrant
Legal Entity Type33 - NOT AVAILABLE
AddressF-21000 DIJON
FR

Party NameONCODESIGN
Party Type20 - Owner at Publication
Legal Entity Type33 - NOT AVAILABLE
AddressF-21000 DIJON
FR

Party NameONCODESIGN
Party Type10 - Original Applicant
Legal Entity Type33 - NOT AVAILABLE
AddressF-21000 DIJON
FR

Trademark Events


Event DateEvent Description
Thursday, July 6, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, July 7, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 7, 2017ASSIGNED TO EXAMINER
Tuesday, July 11, 2017APPLICATION FILING RECEIPT MAILED
Wednesday, July 12, 2017NON-FINAL ACTION WRITTEN
Thursday, July 13, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, July 20, 2017REFUSAL PROCESSED BY MPU
Thursday, July 20, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, August 4, 2017REFUSAL PROCESSED BY IB
Tuesday, December 26, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 26, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 18, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 30, 2018ASSIGNED TO LIE
Wednesday, January 31, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 31, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 31, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 6, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 14, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 21, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 21, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, March 6, 2018PUBLISHED FOR OPPOSITION
Friday, August 16, 2024CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, September 21, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, March 9, 2018NOTIFICATION PROCESSED BY IB
Tuesday, May 22, 2018REGISTERED-PRINCIPAL REGISTER
Wednesday, August 22, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, August 30, 2018FINAL DISPOSITION PROCESSED
Thursday, August 30, 2018FINAL DISPOSITION NOTICE SENT TO IB